Background Despite COVID-19 being identified as severe respiratory viral infection,
progressively many relevant endocrine manifestations have been reported greatly …

Nowadays, humanity faces one of the most serious health crises, the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The severity of coronavirus …

In the past several months, the outbreak of severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2)‐associated infection (coronavirus disease 2019 [COVID‐19]) developed …

Background There are limited antiviral options for the treatment of patients with COVID-19.
Ivermectin (IVM), a macrocyclic lactone with a wide anti-parasitary spectrum, has shown …

Electrolyte abnormalities are not uncommon in coronavirus disease 2019 (COVID-19).
Several studies have suggested that various electrolyte imbalances seem to have an impact …

Background The worldwide spread of SARS-CoV-2 has infected millions of people leading
to over 0.3 million mortalities. The disruption of sodium homeostasis, tends to be a common …

Objectives: Hyponatremia occurs in up to 30% of patients with pneumonia and is associated
with increased morbidity and mortality. The prevalence of hyponatremia associated with …

Coronavirus disease 2019 (COVID-19) infection primarily involves the respiratory system but
has many noteworthy extra pulmonary manifestations as well. We write this review to …

We examined cell type-specific expression and distribution of rat brain angiotensin-
converting enzyme 2 (ACE2), the receptor for SARS-CoV-2, in the rodent brain. ACE2 is …

Objective The pandemic of coronavirus disease (COVID-19) has rapidly spread globally and
infected millions of people. The prevalence and prognostic impact of dysnatremia in COVID …